Director Dere Willard H 🔴 sold 13.6K shares (12 derivative) of Mersana Therapeutics, Inc. (MRSN) at $572.50 ($1.8M) Transaction Date: Jan 06, 2026 | Filing ID: 001382
Director Wolf Jeffrey Alan 🟢 acquired 75.0K shares (1 derivative) of Theriva Biologics, Inc. (TOVX) at $0.24 Transaction Date: Jan 05, 2026 | Filing ID: 001381
Carvajal Alejandra 🔴 sold 39.1K shares (12 derivative) of Mersana Therapeutics, Inc. (MRSN) at $424.50 ($4.0M) Transaction Date: Jan 06, 2026 | Filing ID: 001380
Bala Mohan 🔴 sold 40.4K shares (11 derivative) of Mersana Therapeutics, Inc. (MRSN) at $215.75 ($2.9M) Transaction Date: Jan 06, 2026 | Filing ID: 001379
Director Alleva Lawrence M 🔴 sold 15.9K shares (22 derivative) of Mersana Therapeutics, Inc. (MRSN) at $572.50 ($2.1M) Transaction Date: Jan 06, 2026 | Filing ID: 001377
Kunkel Lori Anne 🟢 acquired 40.0K shares (1 derivative) of Oric Pharmaceuticals, Inc. (ORIC) at $8.17 Transaction Date: Jan 02, 2026 | Filing ID: 000002
Ribeiro Ramiro 🟡 adjusted position in 250.7K shares (3 derivative) of EyePoint, Inc. (EYPT) at $17.48 ($3.1M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
Director York Gwill 🟢 acquired 5.2K shares (1 derivative) of Alto Neuroscience, Inc. (ANRO) at $16.59 Transaction Date: Jan 02, 2026 | Filing ID: 000002